What is Suki?
Suki operates at the intersection of artificial intelligence and clinical workflow optimization. By providing an AI-powered voice platform, the company effectively reimagines the traditional healthcare technology stack. Its primary objective is to render administrative tasks invisible and assistive, allowing healthcare providers to focus on patient care rather than documentation. This market position is supported by a robust history of investment, transitioning from early-stage capital to major enterprise-level financing, which has enabled the company to scale its operations and refine its proprietary machine learning models for diverse clinical environments.
How much funding has Suki raised?
Suki has raised a total of $161.6M across 5 funding rounds:
Series A
$15M
Series B
$20M
Debt
$1.6M
Series C
$55M
Series D
$70M
Series A (2018): $15M with participation from First Round Capital, Venrock, and Social Capital
Series B (2020): $20M led by Breyer Capital, Flare Capital Partners, First Round Capital, Epsilon Health, and Venrock
Debt (2021): $1.6M supported by PPP
Series C (2021): $55M featuring Breyer Capital, Flare Capital Partners, March Capital, Philip Ventures, Venrock, and inHealth Ventures
Series D (2024): $70M backed by Hedosophia Services, Breyer Capital, March Capital, and Venrock
Key Investors in Suki
Breyer Capital
Breyer Capital is an independent global venture capital and private equity investor focusing on long-term, idea-driven investments in artificial intelligence and machine learning.
Venrock
Venrock is a historic venture capital firm that partners with founders to build innovative, high-growth companies, leveraging deep industry expertise in healthcare and technology.
Flare Capital Partners
Flare Capital Partners is a leading investor focused on healthcare technology, collaborating with entrepreneurs to enhance healthcare outcomes and reduce industry costs.
What's next for Suki?
With the infusion of recent capital, Suki is well-positioned to accelerate its product roadmap and expand its footprint within the enterprise healthcare market. The company is expected to leverage this investment to deepen its integration capabilities across electronic health records (EHR) and enhance its natural language processing features. As the healthcare industry continues to prioritize digital transformation, Suki's focus on reducing physician burnout through automation remains a critical value proposition. Future strategic initiatives will likely center on scaling its platform to meet the demands of large-scale health systems, further cementing its role as an essential component of the modern clinical infrastructure.
See full Suki company page
